A European Medicines Agency (EMA) panel said on Friday it has recommended Roche's immunotherapy Tecentriq as a treatment for advanced bladder and... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/OGqRDhhUqCM/us-roche-hldg-tecentriq-eu-idINKBN1A706T
Roche has filed for a patent for its new drug formulation meant for subcutaneous administration ...http://www.business-standard.com/article/companies/roche-s-new-breast-cancer-drug-that-could-cut-treatment-time-denied-patent-117072100240_1.html
Shares in Spanish biotech company Oryzon Genomics plunged 30 percent on Thursday after Swiss drugmaker Roche pulled out of a deal to develop its... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/0lYrkcVX_y4/us-oryzon-roche-idINKBN1A50SZ
(Updates) ** Generic drugmaker's shares up about 2 pct at$39.80 in light premarket trading ** Advisory committee to FDA unanimously recommends... ...http://www.sify.com/finance/buzz-fda-panel-okays-mylan-biocons-copy-of-roches-herceptin-news-others-rhosEqaahfajj.html
Posted by Equitymaster Indian share markets continue to trade near the dotted line during the noon session. Pharma stocks and bank stocks witnessed... ...http://www.equitymaster.com/tm/tm.asp?date=7/14/2017&title=Sensex-Down-37-Points-Infosys-Up-on-Q1-Results
Roche is a Emerging company as a IVR...